Search Results - "Bosch Castells, Valerie"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1
  2. 2

    Purified Vero Cell Rabies Vaccine (PVRV, Verorab): A systematic review of intradermal use between 1985 and 2019 by Moulenat, Thomas, Petit, Céline, Bosch Castells, Valérie, Houillon, Guy

    Published in Tropical medicine and infectious disease (01-03-2020)
    “…The purified Vero cell rabies vaccine (PVRV; Verorab, Sanofi Pasteur) has been used in rabies prevention since 1985. Evolving rabies vaccination trends,…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Using social media listening and data mining to understand travellers’ perspectives on travel disease risks and vaccine-related attitudes and behaviours by Bravo, Catherine, Castells, Valérie Bosch, Zietek-Gutsch, Susann, Bodin, Pierre-Antoine, Molony, Cliona, Frühwein, Markus

    Published in Journal of travel medicine (21-03-2022)
    “…Abstract Background Travellers can access online information to research and plan their expeditions/excursions, and seek travel-related health information. We…”
    Get full text
    Journal Article
  9. 9

    Single-visit, 4-site intradermal (ID) rabies vaccination induces robust immune responses 5 years after 1-week, 4-site ID primary post-exposure prophylaxis in the Philippines by Quiambao, Beatriz P., Ambas, Cristina, Diego, Sherylle, Bosch Castells, Valérie, Korejwo, Joanna, Petit, Céline, Rasuli, Anvar, Houillon, Guy

    Published in Vaccine (06-05-2020)
    “…•Seroconversion >95% persisted at 5 years for the 1-week 4-site ID regimen in Group 1.•Seroconversion persisted between 80 and 90% in Group 2.•Seroconversion…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Post-Marketing Surveillance of Adverse Events Following Vaccination with the Live-Attenuated Japanese Encephalitis Chimeric Virus Vaccine (Imojev®) in South Korea, 2015–2019 by Kim, Hee Soo, Oh, Yongho, Korejwo, Joanna, Castells, Valérie Bosch, Yang, Kuhyun

    Published in Infectious diseases and therapy (01-09-2020)
    “…Introduction The live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV; Imojev ® ) has been approved in South Korea for use in subjects aged ≥…”
    Get full text
    Journal Article
  12. 12

    Immunogenicity and safety of a single dose of a live attenuated Japanese encephalitis chimeric virus vaccine in Vietnam: A single-arm, single-center study by Vu, Thiem Dinh, Nguyen, Quang Dang, Tran, Huong Thi Ai, Bosch-Castells, Valérie, Zocchetti, Céline, Houillon, Guy

    “…•JE-CV is a live attenuated chimeric vaccine against Japanese encephalitis.•It elicited a protective immune response in those aged 9 months–60 years in…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    A Japanese study to assess immunogenicity and safety of a typhoid Vi polysaccharide vaccine by Miyazu, Mitsunobu, Kikuchi, Hitoshi, Hamada, Atsuo, Fukushima, Shinji, Ouchi, Kazunobu, Bosch Castells, Valerie, Mihara, Hanako, Bonnet, Marie-Claude

    Published in Vaccine (27-11-2015)
    “…Highlights • Although rare in Japan, imported cases of typhoid fever can occur in travelers. • Safety and immunogenicity of a typhoid vaccine were assessed in…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20